ADXN
Addex Therapeutics LtdNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$8.12M
P/E Ratio
—
EPS
$-9.16
Beta
1.86
52W High
$12.05
52W Low
$5.41
50-Day MA
$6.79
200-Day MA
$8.01
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Addex Therapeutics Ltd
Addex Therapeutics Ltd, a developing-stage biopharmaceutical company, discovers, develops and markets small molecule pharmaceuticals for central nervous system (CNS) disorders in Switzerland. The company is headquartered in Geneva, Switzerland.
Fundamentals
| Revenue (TTM) | 158,540 |
| Gross Profit (TTM) | -525,653 |
| EBITDA | $-2.46M |
| Operating Margin | -1404.00% |
| Return on Equity | -72.80% |
| Return on Assets | -15.90% |
| Revenue/Share (TTM) | $0.24 |
| Book Value | $7.78 |
| Price-to-Book | 1.07 |
| Price-to-Sales (TTM) | 51.21 |
| EV/Revenue | 160.97 |
| EV/EBITDA | -0.76 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -15.00% |
| Shares Outstanding | $1.23M |
| Float | $92.72M |
| % Insiders | 0.00% |
| % Institutions | 0.06% |
Historical Volatility
HV 10-Day
95.92%
HV 20-Day
93.08%
HV 30-Day
97.33%
HV 60-Day
77.08%
HV Rank
74.2%
Volatility is currently contracting
Data last updated: 4/28/2026